330 related articles for article (PubMed ID: 30829904)
21. Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis.
Kato M; Hayashi Y; Nishida T; Oshita M; Nakanishi F; Yamaguchi S; Kitamura S; Nishihara A; Akasaka T; Ogiyama H; Nakahara M; Yamada T; Kishida O; Yamamoto M; Shimayoshi A; Tsujii Y; Kato M; Shinzaki S; Iijima H; Takehara T
J Gastroenterol Hepatol; 2021 Aug; 36(8):2083-2090. PubMed ID: 33403702
[TBL] [Abstract][Full Text] [Related]
22. The Effect of
Song JH; Yang SY; Lim JH; Choi JM; Kim SG
Korean J Gastroenterol; 2017 Jul; 70(1):27-32. PubMed ID: 28728313
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Helicobacter pylori eradication for the prevention of metachronous gastric cancer after endoscopic resection for early gastric cancer.
Jang JY; Chun HJ
World J Gastroenterol; 2014 Mar; 20(11):2760-4. PubMed ID: 24659868
[TBL] [Abstract][Full Text] [Related]
24. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
Okada K; Suzuki S; Naito S; Yamada Y; Haruki S; Kubota M; Nakajima Y; Shimizu T; Ando K; Uchida Y; Hirasawa T; Fujisaki J; Tsuchida T
Gastrointest Endosc; 2019 Jun; 89(6):1152-1159.e1. PubMed ID: 30825537
[TBL] [Abstract][Full Text] [Related]
25. Preventing metachronous gastric lesions after endoscopic submucosal dissection through Helicobacter pylori eradication.
Jung S; Park CH; Kim EH; Shin SJ; Chung H; Lee H; Park JC; Shin SK; Lee YC; Lee SK
J Gastroenterol Hepatol; 2015 Jan; 30(1):75-81. PubMed ID: 25088761
[TBL] [Abstract][Full Text] [Related]
26. Successful Eradication of Helicobacter pylori Could Prevent Metachronous Gastric Cancer: A Propensity Matching Analysis.
Nakata R; Nagami Y; Hashimoto A; Sakai T; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Ohira M; Taira K; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y
Digestion; 2021; 102(2):236-245. PubMed ID: 31678978
[TBL] [Abstract][Full Text] [Related]
27. Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of
Watari J; Tomita T; Tozawa K; Oshima T; Fukui H; Miwa H
Gut Liver; 2020 May; 14(3):281-290. PubMed ID: 31547640
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
Khan MY; Aslam A; Mihali AB; Shabbir Rawala M; Dirweesh A; Khan S; Adler DG; Siddiqui A
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):686-694. PubMed ID: 32355093
[TBL] [Abstract][Full Text] [Related]
29. Metachronous gastric cancer after successful Helicobacter pylori eradication.
Shiotani A; Haruma K; Graham DY
World J Gastroenterol; 2014 Sep; 20(33):11552-9. PubMed ID: 25206262
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Effects of
Han SJ; Kim SG; Lim JH; Choi JM; Oh S; Park JY; Kim J; Kim JS; Jung HC
Gut Liver; 2018 Mar; 12(2):133-141. PubMed ID: 29069890
[TBL] [Abstract][Full Text] [Related]
31. Effects of Helicobacter pylori eradication on gastric cancer incidence in the Japanese population: a systematic evidence review.
Lin Y; Kawai S; Sasakabe T; Nagata C; Naito M; Tanaka K; Sugawara Y; Mizoue T; Sawada N; Matsuo K; Kitamura T; Utada M; Ito H; Shimazu T; Kikuchi S; Inoue M;
Jpn J Clin Oncol; 2021 Jul; 51(7):1158-1170. PubMed ID: 33893508
[TBL] [Abstract][Full Text] [Related]
32. Incidence of metachronous gastric cancer after endoscopic submucosal dissection associated with eradication status of Helicobacter pylori.
Ikeda R; Hirasawa K; Sato C; Sawada A; Nishio M; Fukuchi T; Kobayashi R; Makazu M; Kaneko H; Maeda S
Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):17-24. PubMed ID: 32483085
[TBL] [Abstract][Full Text] [Related]
33. Association between
Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
[TBL] [Abstract][Full Text] [Related]
34. Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
Iguchi M; Kato J; Yoshida T; Yamamoto Y; Nakachi K; Fukatsu K; Mori Y; Maeda Y; Moribata K; Shingaki N; Niwa T; Deguchi H; Inoue I; Maekita T; Tamai H; Ichinose M
Int J Cancer; 2016 Sep; 139(5):1150-6. PubMed ID: 27083518
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Choi IJ; Kook MC; Kim YI; Cho SJ; Lee JY; Kim CG; Park B; Nam BH
N Engl J Med; 2018 Mar; 378(12):1085-1095. PubMed ID: 29562147
[TBL] [Abstract][Full Text] [Related]
36. Effect of Helicobacter pylori eradication on subsequent dysplasia development after endoscopic resection of gastric dysplasia.
Chon I; Choi C; Shin CM; Park YS; Kim N; Lee DH
Korean J Gastroenterol; 2013 Jun; 61(6):307-12. PubMed ID: 23877210
[TBL] [Abstract][Full Text] [Related]
37. Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development.
Nam SY; Park BJ; Nam JH; Kook MC
Gastrointest Endosc; 2019 Sep; 90(3):448-456.e1. PubMed ID: 31034810
[TBL] [Abstract][Full Text] [Related]
38. Eradication of Helicobacter pylori reduces metachronous gastric cancer after endoscopic resection of early gastric cancer.
Seo JY; Lee DH; Cho Y; Lee DH; Oh HS; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Kim N; Jung HC; Song IS
Hepatogastroenterology; 2013 Jun; 60(124):776-80. PubMed ID: 23165228
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of Primary and Metachronous Gastric Cancers Discovered after
Maehata Y; Nakamura S; Esaki M; Ikeda F; Moriyama T; Hida R; Washio E; Umeno J; Hirahashi M; Kitazono T; Matsumoto T
Gut Liver; 2017 Sep; 11(5):628-634. PubMed ID: 28395508
[TBL] [Abstract][Full Text] [Related]
40. Clinical and endoscopic features of metachronous gastric cancer with possible lymph node metastasis after endoscopic submucosal dissection and Helicobacter pylori eradication.
Suzuki H; Nonaka S; Maetani I; Matsuda T; Abe S; Yoshinaga S; Oda I; Yamagata Y; Yoshikawa T; Saito Y
Gastric Cancer; 2023 Sep; 26(5):743-754. PubMed ID: 37160633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
